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Abstract
Intraoperative parathyroid hormone (IO-PTH) measurements have
been proposed to improve operative success rates in primary, second-
ary and tertiary hyperparathyroidism (PHP, SHP and THP). Thirty-one
patients requiring parathyroidectomy were evaluated retrospectively
from June 2000 to January 2002. Sixteen had PHP, 7 SHP and 8 THP.
Serum samples were taken at times 0 (before resection), 10, 20 and 30
min after resection of each abnormal parathyroid gland. Samples from
28 patients were frozen at -70ºC for subsequent tests, whereas samples
from three patients were tested while surgery was being performed.
IO-PTH was measured using the Elecsys immunochemiluminometric
assay (Roche, Mannheim, Germany). The time necessary to perform
the assay was 9 min. All samples had a second measurement taken by
a conventional immunofluorimetric method. We considered as cured
patients who presented normocalcemia in PHP and THP, and normal
levels of PTH in SHP one month after surgery and who remained in
this condition throughout the follow-up of 1 to 20 months. When rapid
PTH assay was compared with a routine immunofluorimetric assay,
excellent correlation was observed (r = 0.959, P < 0.0001). IO-PTH
measurement showed a rapid average decline of 78.8% in PTH 10 min
after adenoma resection in PHP and all patients were cured. SHP
patients had an average IO-PTH decrease of 89% 30 min after total
parathyroidectomy and cure was observed in 85.7%. THP showed an
average IO-PTH decrease of 91.9%, and cure was obtained in 87.5%
of patients. IO-PTH can be a useful tool that might improve the rate of
successful treatment of PHP, SHP and THP.
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Introduction
Primary hyperparathyroidism (PHP) is a
hypercalcemic disease due to an abnormal
increase in parathyroid hormone (PTH) se-
cretion by one or more parathyroid glands.
The hallmark of this condition is the pres-
ence of high levels of calcium and high or
inappropriate levels of PTH. PHP is more
common in women than men and increases
with age in both sexes (1). Since PHP was
first described, parathyroidectomy has re-
mained the only definitive therapy when the
disease is symptomatic (2). The goal of para-
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thyroidectomy is the excision of the abnor-
mal parathyroid gland(s) with preservation
of the normal ones in order to achieve and
maintain a postoperative normocalcemic state
(3). Success rates for surgical treatment de-
pend on the skill and experience of the sur-
geon in recognizing the pathologic changes
and excising the correct amount of hyper-
functioning parathyroid tissue (4). Several
methods have been proposed to aid the sur-
geon in deciding about the amount of para-
thyroid tissue to be resected. One of these
approaches is intraoperative monitoring of
PTH levels. Since the intact molecule of
PTH containing residues 1 to 84 has a half-
life of only 3 to 4 min (5-9), intraoperative
assays are capable of quantitatively demon-
strating the continued hypersecretion by re-
maining parathyroid tissue after excision of
one or more enlarged glands (10).
Secondary hyperparathyroidism (SHP) is
an acquired disorder most commonly seen in
end-stage renal disease, since the uremic
state presents a continuous stimulus to the
parathyroid gland. About 5 to 10% of pa-
tients with chronic renal failure treated with
long-term dialysis require surgery for SHP
(11). The term tertiary hyperparathyroidism
(THP) is used to describe the evolution of
SHP to a state of apparent autonomous PTH
secretion, resulting in elevated levels of se-
rum calcium resembling PHP (12). In expe-
rienced hands, both subtotal parathyroidec-
tomy and total parathyroidectomy with au-
totransplantation present good therapeutic
results (13). Persistence/recurrence indicates
an inadequate resection of hyperfunctioning
tissue (14,15). Reoperation is necessary for
recurrent SHP in 15% of cases and presence
of supernumerary glands, inadequate initial
parathyroidectomy, and continued hyperpla-
sia of remnant tissue are all potential con-
tributors to this rate of failure (16).
The usefulness of a rapid intraoperative
PTH measurement relates to the need to
avoid postoperative persistent hypercalce-
mia in patients with PHP. Since failure to
cure these patients is most often due to mul-
tiglandular disease not recognized by the
surgeon or due to ectopic adenomas, meas-
urement of intraoperative PTH can reduce
the risk of failure by providing information
about possible reminiscent tissue (10,17).
Another potential utility of intraoperative
PTH is in minimally invasive surgeries and
the need to achieve high cure rates with this
procedure (18).
As in PHP, the intraoperative determina-
tion of intact PTH may be useful in surgery
of patients with chronic renal failure and
hyperparathyroidism, suggesting missed or
hyperfunctioning supernumerary glands,
when levels fail to decrease after parathyroid
tissue removal (19). The aim of the present
study was to observe retrospectively the de-
cay profile of intact PTH in patients under-
going parathyroidectomy for PHP, refratory
SHP or THP and to compare it to the cure
observed in postoperative follow-up, in or-
der to assess the utility of this procedure in
predicting cure.
Patients and Methods
Patients
Thirty-one patients requiring parathy-
roidectomy were evaluated retrospectively
during a period of 20 months (June 2000 to
January 2002) at Escola Paulista de Medi-
cina, Federal University of São Paulo, São
Paulo, SP, Brazil. Sixteen had PHP, and
fifteen had hyperparathyroidism related to
chronic renal failure. Diagnosis of PHP was
based on clinical features and confirmed by
the findings of high total and/or ionized cal-
cium levels, and high or inappropriate levels
of intact PTH associated with normal renal
function. Criteria for surgery in PHP were
based on rules established by the National
Institutes of Health (NIH, Bethesda, MD,
USA) Consensus Conference of 1990 (20).
Among the patients with hyperparathy-
roidism secondary to chronic renal failure,
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7 had refractory SHP in dialysis treatment
and 8 had THP (6 with renal transplantation
and functioning grafts and 2 in dialysis treat-
ment). Refractory SHP patients had severe
SHP without hypercalcemia, and the term
THP was used to describe the evolution of
SHP to a state of apparent autonomous PTH
secretion, resulting in elevated levels of se-
rum calcium resembling PHP (12).
Specific indications for parathyroidec-
tomy in hyperparathyroidism related to renal
disease include a) persistent hypercalcemia,
b) intractable pruritus not responding to in-
tensive dialysis or to other medical interven-
tions, c) progressive extraskeletal calcifica-
tions and/or persistent hyperphosphatemia
despite the continued use of dietary phos-
phorus restriction and phosphate-binding
agents, d) severe bone pain or fractures, and
e) the development of calciphylaxis (21).
Patients were divided into three groups:
the first included those with PHP, the second
patients with refractory SHP and the third
group patients with THP. Data analysis was
carried out on these groups because of the
particular characteristics and evolution of
the patients. Characteristics of patients and
preoperative laboratory findings are shown
in Table 1. This study was approved by the
University Ethics Committee (approval No.
886/00) and informed consent was obtained
from all patients.
Methods
Baseline peripheral venous blood samples
were obtained immediately after induction
of anesthesia. After the parathyroid adenoma
was removed, additional samples were col-
lected at 10, 20 and 30 min after excision.
When patient presented with multiglandular
disease, blood samples were obtained 10, 20
and 30 min after each glandular excision.
Samples from 28 patients were frozen at
-70ºC for subsequent tests, whereas samples
from 3 patients were tested while surgery
was being performed.
PTH was measured by the Elecsys PTH
Immunoassay (Elecsys 1010 System, Roche,
Mannheim, Germany). The test is an immu-
nometric assay based on monoclonal anti-
bodies, magnetic particles as the solid phase
and ruthenium complex as the chemilumi-
nescent label. The time needed to perform
the assay was 9 min. Analytical sensitivity
(lower detection limit) was 1.20 pg/ml. To
validate the rapid PTH assay, 170 samples
were also submitted to a standard immuno-
fluorimetric assay (22). During the postop-
erative follow-up (1 to 20 months after sur-
Table 1. Characteristics of patients and preoperative laboratory findings.
Primary HP Secondary HP Tertiary HP
No. of patients 16 7 8
Sex (female:male) 10:6 4:3 5:3
Mean age (years) 52 (12-80) 31.7 (22-58) 40 (23-54)
Mean preoperative iPTH 248.6 (86-1019) 1312.5 (248-2500) 503.2 (140-1774)
(RV: 10-70 pg/ml)
Mean preoperative ionized 1.45 (1.32-1.89) 1.20 (1.13-1.27) 1.56 (1.37-2.06)
calcium (RV: 1.12-1.32 mmol/l)
Years on dialysis 6 (3-14) 7.8 (4-14)
Years of renal graft (N = 6) 1.5 (0.16-4)
HP, hyperparathyroidism; iPTH, intact parathyroid hormone; RV, reference value. Range is shown in paren-
theses.
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times 10 and 20 min (P = 0.0170) and be-
tween times 20 and 30 min (P = 0.0027) after
resection.
It is interesting to note that in PHP with
multiglandular disease (N = 2), as expected,
the decay profile was different from that for
uniglandular disease, with a stepwise de-
crease in intraoperative PTH concentrations
following each gland removal. The percent
changes in PTH from baseline for the 14
patients with PHP with uniglandular disease
are presented in Figure 2A and the decay
profile for PHP patients with multiglandular
disease is presented in Figure 2B.
All patients with PHP were considered
cured during the postoperative follow-up,
with a mean 78.8% reduction in PTH levels,
suggesting that the assay could predict cure
in this group of patients.
As expected when multiglandular dis-
ease is involved, measurements of intraop-
erative rapid intact PTH in refractory SHP
patients followed a sequential decrease pat-
tern after each gland removal. Patients with
refractory SHP showed a mean intact PTH
decrease of 89% 30 min after total parathy-
roidectomy, indicating high cure rates. In
this group, cure was observed in 85.7% (6/7)
of patients. In 5 of these 7 refractory SHP
patients, intact PTH absolute values in the
final intraoperative samples were still high
(mean 128.5 pg/ml, range: 83-311 pg/ml),
but during the postoperative follow-up 85.7%
of SHP patients were considered cured. The
PTH decrease observed in THP patients re-
sembled that observed in PHP, with a faster
PTH reduction than observed in SHP (Figure
2C). Patients with THP had a mean rapid
intact PTH decay of 91.9% from baseline 30
min after removal of all recognized parathy-
roid tissue, with a cure rate of 87.5% (7/8).
Discussion
Failure to surgically cure hyperparathy-
roidism is usually related to multiglandular
disease, ectopic adenomas, misinterpretation
gery), we considered as cured patients who
presented normocalcemia in the case of PHP
and THP, and normal PTH levels in SHP.
Serum total calcium, phosphorus, total
alkaline phosphatase and urinary calcium
were measured by standard automatic assays.
Serum ionized calcium was measured using
an ion-specific electrode (AVL 9180 Elec-
trolyte Analyzer, Roswell, GA, USA), with a
reference value of 1.12 to 1.32 mmol/l.
Statistical analysis
Data were analyzed by the paired t-test
and Spearman correlation test. A P value of
<0.05 was considered to be significant.
Results
The correlation between the rapid PTH
assay and the standard immunofluorimetric
assay was r = 0.959 (P < 0.0001) (Figure 1).
Among the 16 patients with PHP, 14 had
uniglandular disease and 2 multiglandular
disease. In the 14 patients with PHP and
uniglandular disease there was an average
decrease of 78.8% in intact PTH concentra-
tions 10 min after abnormal parathyroid re-
section. Intact PTH levels continued to fall
20 and 30 min after abnormal parathyroid
removal by about 83.7 and 87.1% from the
baseline values, respectively. There was a
significant difference in PTH values between
Figure 1. Correlation between the
results of rapid intraoperative in-
tact parathyroid hormone (PTH)
determined by the Elecsys immu-
nochemiluminometric assay and
by a standard immunofluorimetric
assay (IFMA). N = number of pa-
tients; r = correlation coefficient.
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of frozen-section pathologic findings, and
incorrect diagnosis of PHP (23,24). Attempt-
ing to decrease failure rates, experienced
surgeons have reported large series with ex-
cellent results using different surgical ap-
proaches to parathyroidectomy (25). Surgi-
cal treatment of PHP has undergone some
changes in recent years. The standard tech-
nique of bilateral neck exploration with iden-
tification of parathyroid adenoma together
with the three other normal glands is being
replaced in selected cases at many medical
centers with a less time-consuming proce-
dure of unilateral neck exploration based on
preoperative localization by 99mTC-sestamibi
scans (26). The utility of a test that can
assure the surgeon that multiglandular dis-
ease is not present after the excision of a
large parathyroid gland, or that can help
localize intraoperatively an eluding adenoma,
and quantitatively confirm the adequate ex-
cision, is clear.
Secretion of PTH is suppressed in the
remaining normal parathyroid glands after
removal of all hyperfunctioning tissue (9)
and this, coupled with the rapid clearance of
intact PTH, allows the measurement of intra-
operative PTH to determine its disappear-
ance rates. The clinical utility of rapid intra-
operative PTH measurements in parathy-
roidectomy was first reported in 1988 using
a modified intact PTH immunoradiometric
assay (27). The authors observed that PTH
concentrations declined to a mean of 40% of
baseline values 15 min after successful para-
thyroid adenomectomy in 12 patients, and
they suggested that the surgical judgment
and skill of the surgeon to determine surgical
cure could be complemented with the intra-
operative PTH assay.
Thereafter, rapid assays were developed
using radioactive (4,28,29) as well as nonra-
dioactive formats (10,30). Irvin III and Deriso
(10) documented an immunochemilumino-
metric assay for intact PTH (Nichols Insti-
tute Diagnostics, San Juan Capistrano, CA,
USA) for use as a rapid intraoperative PTH
assay in surgery for PHP, and reported a
sensitivity of 97%, specificity of 100%, and
an overall accuracy of 97% (31). Gordon
and co-workers (32) suggested that a 50%
decrease in the 10-min post-excision sample
accurately predicts the disease state in 89%
of patients with PHP. Findings of 88% accu-
racy in predicting cure using the criterion of
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Figure 2. Intraoperative circulat-
ing concentrations of intact para-
thyroid hormone (PTH) during
parathyroid gland resection. In-
tact PTH was determined by the
9-min Elecsys assay system. A,
Reduction of intact PTH in 14
primary hyperparathyroid pa-
tients with a single adenoma.
Data are reported as percent. B,
Reduction of intact PTH (pg/ml)
in primary hyperparathyroid pa-
tients with multiglandular dis-
ease. Arrows indicate parathy-
roid gland resection. C, Intact
PTH concentration (pg/ml) of 8
tertiary hyperparathyroid pa-
tients.
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a 50% decrease at 5-10 min have been re-
ported, and of 97% if patients with delayed
decreases of intraoperative PTH are included
(33).
The assay used in the present study
showed a good correlation with a standard
PTH immunofluorimetric assay used in our
routine (r = 0.959, P < 0.0001) and docu-
mented the rapid decline in PTH levels after
excision of significant amounts of parathyroid
tissue, as previously described by other au-
thors (4,10,27,29,30,33) with similar assays.
All patients with PHP were considered to
be cured after parathyroidectomy and this
correlated with an average 78.8% reduction
of PTH values from baseline at 10 min after
adenoma removal, confirming the ability of
the assay to predict cure. Patients with SHP
showed an average decrease of 89% 30 min
after parathyroidectomy with the assay show-
ing the ability to predict cure in 85.7% of
patients. Even if final intraoperative PTH
levels were still high in SHP patients, the
postoperative follow-up showed normal PTH
levels in 85.7%. This pattern of delayed PTH
clearance has been described in SHP pa-
tients receiving dialysis compared to patients
with normal renal function (19). The de-
creased renal function might explain the fi-
nal abnormal intraoperative PTH levels in
patients that eventually were considered to
be cured. In these cases it may be of interest
to consider the percent decay in intraopera-
tive PTH values, instead of absolute values
after total parathyroidectomy. Among pa-
tients with THP, the rapid PTH decay profile
showed a pattern resembling PHP, probably
due to the presence of a functioning renal
graft in these patients (N = 6). In THP pa-
tients, intraoperative PTH was able to pre-
dict cure in 87.5% of cases, with a mean
91.9% decrease in PTH values from baseline
to 30 min after parathyroidectomy. In con-
clusion, the rapid PTH assay used in this
study might be useful to improve success
rates in parathyroidectomy surgeries in pri-
mary, secondary and tertiary hyperparathy-
roidism.
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